Growth & profitability
- Revenue has declined 4.5% per year over the past 5 years.
Financial health
- The company holds more cash ($5.4B) than total debt ($3.2B).
- Total debt has grown in line with revenue (-1.7% vs -4.5% per year).
11 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $6.8B | $331M | 0.0% | 0.0% | — | $3.2B | $5.4B |
| 2024 | $4.7B | $286M | 0.0% | 0.0% | — | $3.2B | $5.0B |
| 2023 | $4.1B | -$1.2B | 0.0% | 0.0% | — | $3.2B | $3.9B |
| 2022 | $6.9B | $3.8B | 0.0% | 0.0% | — | $3.2B | $4.1B |
| 2021 | $5.0B | $1.6B | 0.0% | 0.0% | — | $3.2B | $4.5B |
| 2020 | $8.5B | -$1.1B | 0.0% | 0.0% | — | $3.4B | $4.1B |
| 2019 | $6.6B | -$740M | 0.0% | 0.0% | — | $4.4B | $2.9B |
| 2018 | $9.0B | $865M | 0.0% | 0.0% | — | $4.0B | $4.1B |
| 2017 | $6.8B | -$378M | 0.0% | 0.0% | — | $3.6B | $1.9B |
| 2016 | $3.0B | — | 0.0% | 0.0% | — | $1.9B | $5.2B |
| 2015 | $8.9B | — | 0.0% | 0.0% | — | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1.5B | -$766M | 0.0% | 0.0% | — | $3.2B | $4.9B |
| Dec '25 | $1.7B | $137M | 0.0% | 0.0% | — | $3.2B | $5.4B |
| Sep '25 | $1.8B | $479M | 0.0% | 0.0% | — | $3.2B | $6.6B |
| Jun '25 | $871M | $85M | 0.0% | 0.0% | — | $3.2B | $5.5B |
| Mar '25 | $2.4B | -$268M | 0.0% | 0.0% | — | $3.2B | $4.7B |
| Dec '24 | $1.2B | $671M | 0.0% | 0.0% | — | $3.2B | $5.0B |
| Sep '24 | $2.0B | $176M | 0.0% | 0.0% | — | $3.2B | $5.6B |
| Jun '24 | $1.4B | $34M | 0.0% | 0.0% | — | $3.2B | $4.4B |
| Mar '24 | $74M | -$493M | 0.0% | 0.0% | — | $3.2B | $3.8B |
| Dec '23 | $1.4B | -$917M | 0.0% | 0.0% | — | $3.2B | $3.9B |
| Sep '23 | $1.2B | $479M | 0.0% | 0.0% | — | $3.2B | $3.8B |
| Jun '23 | $263M | -$175M | 0.0% | 0.0% | — | $3.2B | $3.7B |
| Mar '23 | $1.3B | -$499M | 0.0% | 0.0% | — | $3.2B | $3.7B |
| Dec '22 | -$127M | $136M | 0.0% | 0.0% | — | $3.2B | $4.1B |
| Sep '22 | $1.1B | $413M | 0.0% | 0.0% | — | $3.2B | $4.8B |
| Jun '22 | $3.9B | $1.7B | 0.0% | 0.0% | — | $3.2B | $5.1B |
| Mar '22 | $2.0B | $1.6B | 0.0% | 0.0% | — | $3.2B | $4.1B |
| Dec '21 | $2.0B | $63M | 0.0% | 0.0% | — | $3.2B | $4.5B |
| Sep '21 | $2.5B | $383M | 0.0% | 0.0% | — | $3.4B | $4.1B |
| Jun '21 | $1.7B | $31M | 0.0% | 0.0% | — | $3.4B | $4.9B |
How the market has priced BHFAO against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Brighthouse Financial, Inc.'s revenue has declined 4.5% per year. These are computed facts, not advice.
As of FY2025, Brighthouse Financial, Inc. reported $3.2B of total debt against $5.4B of cash.
In FY2025, gross margin was —, operating margin —, and net margin 4.9%.
As of Jun '26, Brighthouse Financial, Inc. traded at a price-to-earnings ratio of about 2.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.